GGrantIndex
Sort

25,944 grants matching neurodegeneration

Boston Latino Aging Study (BLAST): Understanding Alzheimer's risk and biomarkers in older Latinos

$822,778
Yakeel T. Quiroz · Massachusetts General Hospital · R01 · FY2025 · AG

Validating Automated Photoreceptor Analytics Software For Degenerative Eye Disease Research and Biopharma Clinical Trials.

$822,761
Eric L. Buckland · Translational Imaging Innovations, Inc. · R44 · FY2021 · EY

Impact of Toxic Metal Exposures in Novel Genetic Mouse Models of Late-Onset Alzheimer's Disease

$822,643
Lee E Goldstein · Boston University Medical Campus · R56 · FY2023 · AG

Re-visiting Methods for MCI Diagnosis to Improve Biomarker and Trial Findings

$822,079
Mark W Bondi · University Of California, San Diego · R01 · FY2016 · AG

Transgenic Huntington's disease monkey resource

$821,996
Anthony Wing Sang Chan · Emory University · R24 · FY2018 · OD

Hypothalamic AgRP Neurons Are Determinants of Healthy Lifespan and Higher Brain

$821,907
Tamas L Horvath · Yale University · DP1 · FY2012 · DK

Vascular contributions to HIV-associated Neurocognitive Disorders (HAND)

$821,867
Jose Gutierrez · Columbia University Health Sciences · R01 · FY2022 · AG

Optimizing integration of veterinary clinical research findings with human health systems to improve strategies for early detection and intervention

$821,833
Cheryl A London · Tufts University Boston · RC2 · FY2024 · TR

Auditory, olfactory, and motor correlates of in-vivo AD neuropathology and cognitive decline in late-middle age

$821,822
Jose A Luchsinger · Columbia University Health Sciences · R56 · FY2019 · AG

Cellular and Genetic Origins of Astrocytes

$821,578
David H Rowitch · University Of California, San Francisco · R01 · FY2008 · NS

Sphingolipid Biology of Neurodegeneration

$821,451
Richard Proia · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2021 · DK

Programs for generating inhibitory interneuron diversity and connectivity

$821,163
Kristin Kay Baldwin · Columbia University Health Sciences · R01 · FY2024 · MH

Chemical Approaches to Understand O-GlcNAc Glycosylation and Its Roles in Neurodegeneration

$821,056
Linda C Hsieh-Wilson · California Institute Of Technology · R01 · FY2024 · AG

Modeling and Pathological Study of Sporadic Parkinson's Disease

$821,045
Huaibin Cai · National Institute On Aging · ZIA · FY2016 · AG

Genetic etiology of Amyotrophic Lateral Sclerosis

$820,911
Bryan Traynor · National Institute On Aging · ZIA · FY2017 · AG

Genetics-informed dissection of human brain cell-cell communication in Alzheimer's disease progression

$820,536
Bingshan Li · Vanderbilt University · R01 · FY2024 · AG

Control of Cholesterol Metabolism --Bile Acid Transport

$820,465
John M. Dietschy · Ut Southwestern Medical Center · R01 · FY2008 · HL

Neuroprotective and neuroregenerative effects of Bone morphogenetic proteins

$820,336
Yun Wang · National Institute On Drug Abuse · Z01 · FY2007 · DA

Roles of Cdk5 in neurodevelopment and neurodegeneration

$820,176
Edward Giniger · National Institute Of Neurological Disorders And Stroke · ZIA · FY2015 · NS

Emotion alterations across the Alzheimer's disease spectrum

$820,088
Virginia Emily Sturm · University Of California, San Francisco · R01 · FY2021 · AG

Auditory event-related potentials as in vivo preclinical assays of circuit engagement for E/I-based therapeutic development

$819,484
Daniel C. Javitt · Nathan S. Kline Institute For Psych Res · R01 · FY2023 · MH

Hypothalamic AgRP neurons are determinants of healthy lifespan and higher brain f

$819,431
Tamas L Horvath · Yale University · DP1 · FY2011 · OD

Imaging Mass Spectrometry-Based Metabolomic Analysis of the Alzheimer's Brain

$818,662
Valina L. Dawson · Johns Hopkins University · R01 · FY2024 · AG

Imaging Mass Spectrometry-Based Metabolomic Analysis of the Alzheimer's Brain

$818,662
Valina L. Dawson · Johns Hopkins University · R01 · FY2022 · AG

Imaging Mass Spectrometry-Based Metabolomic Analysis of the Alzheimer's Brain

$818,662
Valina L. Dawson · Johns Hopkins University · R01 · FY2023 · AG